Benjamin J. Hindson is of 10x Genomics, Inc.. Currently has a direct ownership of 345,704 shares of TXG, which is worth approximately $5.59 Million. The most recent transaction as insider was on Dec 01, 2021, when has been sold 41,666 shares (Class A Common Stock) at a price of $30.37 per share, resulting in proceeds of $1,265,396. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 346K
1.24% 3M change
23.12% 12M change
Total Value Held $5.59 Million

Benjamin J. Hindson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2021
BUY
Exercise of conversion of derivative security
$1,265,396 $30.37 p/Share
41,666 Added 32.03%
88,432 Class A Common Stock
Nov 22 2021
SELL
Open market or private sale
$52,081 $148.38 p/Share
351 Reduced 0.74%
46,766 Class A Common Stock
Nov 01 2021
SELL
Open market or private sale
$6,786,141 $162.87 p/Share
41,666 Reduced 46.93%
47,117 Class A Common Stock
Nov 01 2021
BUY
Exercise of conversion of derivative security
$344,161 $8.26 p/Share
41,666 Added 31.94%
88,783 Class A Common Stock
Oct 01 2021
SELL
Open market or private sale
$5,979,487 $143.51 p/Share
41,666 Reduced 46.93%
47,117 Class A Common Stock
Oct 01 2021
BUY
Exercise of conversion of derivative security
$209,997 $5.04 p/Share
41,666 Added 31.94%
88,783 Class A Common Stock
Sep 01 2021
SELL
Open market or private sale
$7,376,132 $177.03 p/Share
41,666 Reduced 46.93%
47,117 Class A Common Stock
Sep 01 2021
BUY
Exercise of conversion of derivative security
$209,997 $5.04 p/Share
41,666 Added 31.94%
88,783 Class A Common Stock
Aug 23 2021
SELL
Open market or private sale
$54,543 $161.85 p/Share
337 Reduced 0.71%
47,117 Class A Common Stock
Aug 02 2021
SELL
Open market or private sale
$7,565,296 $181.57 p/Share
41,666 Reduced 46.75%
47,454 Class A Common Stock
Aug 02 2021
BUY
Exercise of conversion of derivative security
$129,998 $3.12 p/Share
41,666 Added 31.86%
89,120 Class A Common Stock
Jul 01 2021
SELL
Open market or private sale
$8,026,122 $192.63 p/Share
41,666 Reduced 46.75%
47,454 Class A Common Stock
Jul 01 2021
BUY
Exercise of conversion of derivative security
$49,999 $1.2 p/Share
41,666 Added 31.86%
89,120 Class A Common Stock
Jun 01 2021
SELL
Open market or private sale
$7,318,633 $175.65 p/Share
41,666 Reduced 46.75%
47,454 Class A Common Stock
Jun 01 2021
BUY
Exercise of conversion of derivative security
$49,999 $1.2 p/Share
41,666 Added 31.86%
89,120 Class A Common Stock
May 24 2021
SELL
Open market or private sale
$57,094 $162.66 p/Share
351 Reduced 0.73%
47,454 Class A Common Stock
May 03 2021
SELL
Open market or private sale
$8,031,955 $192.77 p/Share
41,666 Reduced 53.21%
36,636 Class A Common Stock
May 03 2021
BUY
Exercise of conversion of derivative security
$47,499 $1.14 p/Share
41,666 Added 34.73%
78,302 Class A Common Stock
Apr 01 2021
SELL
Open market or private sale
$7,641,544 $183.4 p/Share
41,666 Reduced 53.21%
36,636 Class A Common Stock
Apr 01 2021
BUY
Exercise of conversion of derivative security
$44,583 $1.07 p/Share
41,666 Added 34.73%
78,302 Class A Common Stock
Mar 19 2021
BUY
Grant, award, or other acquisition
-
11,169 Added 18.94%
47,805 Class A Common Stock
Mar 12 2021
SELL
Open market or private sale
$6,541,978 $157.01 p/Share
41,666 Reduced 53.21%
36,636 Class A Common Stock
Mar 12 2021
BUY
Exercise of conversion of derivative security
$40,833 $0.98 p/Share
41,666 Added 34.73%
78,302 Class A Common Stock
Feb 01 2021
SELL
Open market or private sale
$5,949,787 $176.29 p/Share
33,750 Reduced 47.95%
36,636 Class A Common Stock
Jan 04 2021
SELL
Open market or private sale
$4,731,750 $140.2 p/Share
33,750 Reduced 32.41%
70,386 Class A Common Stock
BJH

Benjamin J. Hindson

Pleasanton, CA

Track Institutional and Insider Activities on TXG

Follow 10x Genomics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG